Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on ...

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative ...

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products ...

Mangoceuticals (MGRX) said it strongly refutes claims made in a lawsuit filed by Eli Lilly (LLY) over a compounded version of ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

Mangoceuticals (MGRX) learned earlier this morning that Eli Lilly (LLY) has made certain public claims alleging, and has stated that it ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...

The latest update is out from Mangoceuticals, Inc. ( (MGRX) ).

Vice President Kamala Harris wants more drugs to be negotiated by Medicare, but her plan to implement an expansion if elected president remains unclear.

MangoRx aims to capitalize on growing demand for GLP-1 treatments to drive revenue growth and expand market share in the ...